⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

June 21, 2024Diabetes Research and Clinical PracticeOpen Access

Real-world effectiveness of imeglimin in patients with type 2 diabetes: A retrospective longitudinal study in Japan

Hisayuki Katsuyama Mariko Hakoshima Takahiro Heshiki Sakura Iida Hiroki Adachi Hidekatsu Yanai

View Full Paper

Ask AI

Bookmark

Share

Abstract

To examine the real-world effects of imeglimin on glycemic control and other metabolic factors in patients with type 2 diabetes (T2DM).

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Katsuyama et al. (2024) studied this question.

synapsesocial.com/papers/68e63c18b6db6435875ce15d https://doi.org/10.1016/j.diabres.2024.111752

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Imeglimin for Type 2 Diabetes Mellitus: Its Efficacy and Insight Into the Potential Benefit for Renal and Liver Function2024 · 8 citations
2Factors contributing to the clinical effectiveness of imeglimin monotherapy in Japanese patients with type 2 diabetes mellitus2024 · 3 citations
31789-P: Age and the Efficacy of Imeglimin in Type 2 Diabetes: A Three-Month, Real-World Study in Japanese Patientscohort · 2026
4907-P: The Effect of Imeglimin on Glycemic Management in Japanese Patients with Type 2 Diabetes2024
52868-LB: Durable Glycemic Control and Improved Patient-Reported Outcomes with Imeglimin: Eighteen-Month Real-World Evidence from IndiaRCT · 2026